These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15896181)

  • 1. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
    Martin DD; Shephard MD; Freeman H; Bulsara MK; Jones TW; Davis EA; Maguire GP
    Med J Aust; 2005 May; 182(10):524-7. PubMed ID: 15896181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care testing of capillary glucose in the exclusion and diagnosis of diabetes in remote Australia.
    Marley JV; Davis S; Coleman K; Hayhow BD; Brennan G; Mein JK; Nelson C; Atkinson D; Maguire GP
    Med J Aust; 2007 May; 186(10):500-3. PubMed ID: 17516895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional comparison of point-of-care with laboratory HbA₁c in detecting diabetes in real-world remote Aboriginal settings.
    Marley JV; Oh MS; Hadgraft N; Singleton S; Isaacs K; Atkinson D
    BMJ Open; 2015 Mar; 5(3):e006277. PubMed ID: 25765020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Bayer DCA 2000+ for the measurement of glycated haemoglobin in a remote Australian Aboriginal community.
    Shemesh T; Piers LS; O'Dea K
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):566-8. PubMed ID: 14503997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using glycated haemoglobin testing to simplify diabetes screening in remote Aboriginal Australian health care settings.
    Marley JV; Oh MS; Hadgraft NT; Singleton SL; Isaacs K; Atkinson DN
    Med J Aust; 2015 Jul; 203(1):28-32. PubMed ID: 26126564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
    Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
    Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
    Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
    Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between glycated haemoglobin levels and mean glucose levels over time.
    Nathan DM; Turgeon H; Regan S
    Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of IFCC-calibrated HbA(1c) from laboratory and point of care testing systems.
    Manley SE; Hikin LJ; Round RA; Manning PW; Luzio SD; Dunseath GJ; Nightingale PG; Stratton IM; Cramb R; Sikaris KA; Gough SC; Webber J
    Diabetes Res Clin Pract; 2014 Sep; 105(3):364-72. PubMed ID: 24985893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
    Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
    Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HbA1c combined FPG on screening diabetes in health check-up.
    Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
    Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
    Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
    Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
    Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
    Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.
    Manley SE; Sikaris KA; Lu ZX; Nightingale PG; Stratton IM; Round RA; Baskar V; Gough SC; Smith JM
    Diabet Med; 2009 Feb; 26(2):115-21. PubMed ID: 19236612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of longitudinal point-of-care and high-performance liquid chromatography HbA1c measurements in a multi-centre trial.
    Alleyn CR; Laffel LM; Volkening LK; Anderson BJ; Nansel TR; Wysocki T; Weissberg-Benchell J
    Diabet Med; 2011 Dec; 28(12):1525-9. PubMed ID: 21824185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).
    Liberopoulos EN; Florentin M; Kei A; Mountzouri E; Agouridis A; Elisaf MS
    J Clin Hypertens (Greenwich); 2010 Jul; 12(7):543-8. PubMed ID: 20629819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey.
    Bao Y; Ma X; Li H; Zhou M; Hu C; Wu H; Tang J; Hou X; Xiang K; Jia W
    BMJ; 2010 May; 340():c2249. PubMed ID: 20478961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.